Pharmaceutical Contract Manufacturing and Development Organization Market Report with – Famar, Boehringer, Pfizer


Pharmaceutical contract development and manufacturing organization cdmo market

Stratistics MRC Report, Wearable Robots and Exoskeleton Market Forecast to 2027 – Global Analysis Application, Key Players, Types, End User and by Geography

MARYLAND, GAITHERSBURG, UNITED STATES, October 18, 2021 / – The global pharmaceutical contract development and manufacturing organization (CDMO) market is worth $ 148.50 billion in 2019 and is expected to reach $ 298.07 billion by 2027, with a CAGR of 9, 1% over the forecast period. Some of the key factors propelling the market growth include the increasing demand for generic drugs and biologics, the growing need for advanced production processes and technologies, the advent of the contract development and manufacturing organization model ( CDMO) and growing investment in R&D. However, strict government regulations are likely to hamper the market.

By type of service, the pharmaceutical manufacturing services segment is expected to grow at a lucrative rate during the forecast period, owing to the increasing need to reduce manufacturing costs, the requirement of high bulk manufacturing. quality, growing demand for generic drugs, high cost of operations, and lack of in-house manufacturing capacity.

Some of the major players in the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market include Famar SA, Boehringer Ingelheim Group, Catalent Inc., Pfizer CentreSource, CMIC Holdings Co. Ltd, Aenova Holding GmbH, Baxter Biopharma Solutions, Syneos Health Inc., Lonza Group, Patheon Inc., Novotech Pty Ltd, Covance Inc., Recipharm AB, SGS SA (SGS Life Sciences), Jubilant Life Sciences Ltd, Samsung Bioepis Co. Ltd, IQVIA Holdings Inc., Quanticate Ltd, PAREXEL International Corporation and WuXi AppTec Inc.

Browse the in-depth table of contents on the “Pharmaceutical Contract Development and Manufacturing Organization Market” @

On the basis of geography, Asia-Pacific is expected to experience significant market growth during the forecast period, due to the low cost offered by the region, compared to the United States and other developed economies. . In addition, the increasing incidence of chronic and lifestyle-related diseases, such as diabetes and heart disease, coupled with the ease of patient recruitment and the availability of expertise for clinical trials, is low. factors stimulating growth in the region. With the increasing privatization of clinical trials, there has been an increase in the outsourcing of research processes to developing regions like China and India.

Get a copy of this research @

The Pharmaceutical CDMO market report provides in-depth study and industry forecast covering the comprehensive overview of the market which will help convey the customers and start-up strategies. The industry’s supply chain and market size, in terms of value, have been determined through extensive research methods. Our report enables readers to understand market details, latest trends, key drivers and restraints, opportunities, threats, volume and value forecast, and various investment opportunities for manufacturers operating in the global markets and regional. The Pharmaceutical CDMO market report also offers company profiling with detailed strategies, financial data, key products and recent developments along with SWOT analysis of profiled players and Porters’ five forces for insight. thorough.

This report offers market surveillance related to a particular area of ​​customer interest and provides up-to-date information related to strategic initiatives such as mergers, acquisitions, partnerships, expansions, product launches for major companies on a regional scale. depending on the subscription period of customers for various industries or markets. Our data is constantly updated and reviewed by a team of research experts to always reflect recent trends and information. We have extensive experience in research and consulting for different areas of activity to meet the needs of individual and corporate clients. Our experienced team uses proprietary data sources and different tools and methods to collect and analyze information.

Browse the latest Stratistics MRC market research reports:

Unlined Label Market Forecast to 2028 – Global analysis by product (variable information printing, primary, variable image), printing ink (solvent-based, water-based, ultraviolet (UV) curable, oil-based) and by geography

Flexible Plastic Bag Market Forecast to 2028 – Global analysis by material (polyamide, polyvinyl chloride (PVC), polyethylene (PE)), type (flat bags, upright bags) and by geography

Sterile Packaging Market Forecast to 2028 – Global analysis by material (glass, plastic, non-woven, metals, paper and cardboard), product (bags and pouches of solution, shells, vials, sterile closures, packaging) and by geography

About Us:
Stratistics MRC research reports and publications are channeled to help clients design their business models and improve their business growth in a competitive market scenario. We have a strong team of handpicked consultants including project managers, performers, industry experts, researchers, research evaluators and analysts with years of experience in delivering complex projects. We follow more than 30 industries and cover 800 market segments.

Call us at + 1-301-202-5929 now for personal assistance with your questions.
Email: [email protected]
Follow us on LinkedIn:
Follow us on twitter:
See all exclusive Covid-19 reports @

Consulting in market research strategy Pvt Ltd
+1 301-202-5929
write us here
Visit us on social networks:


Previous Colombian government sterilized Pablo Escobar's "cocaine hippos" for environmental reasons
Next The Colombian government is preparing to sterilize them